P-016 Resistance to apoptosis in high-risk myelodysplastic syndrome can be overcome by pro-apoptotic drug treatment using ABT-737
| Autor: | Jilg, S., König, J., Höckendorf, U., Schauwecker, J., Huberle, C., Müller-Thomas, C., Schmidt, B., Burgkart, R., Götze, K., Kolb, H.J., Peschel, C., Jost, P.J. |
|---|---|
| Zdroj: | In Leukemia Research May 2013 37 Supplement 1:S29-S30 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect